- Home
- MSM vs OGN Comparison
MSM vs OGN Comparison
Compare MSM & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSM | OGN |
|---|---|---|
| Founded | 1941 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 1.8B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | MSM | OGN |
|---|---|---|
| Price | $86.47 | $6.87 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 5 |
| Target Price | ★ $91.25 | $14.10 |
| AVG Volume (30 Days) | 649.6K | ★ 4.8M |
| Earning Date | 01-07-2026 | 11-10-2025 |
| Dividend Yield | ★ 4.03% | 1.17% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.57 | 1.91 |
| Revenue | $3,769,521,000.00 | ★ $6,301,000,000.00 |
| Revenue This Year | $6.46 | N/A |
| Revenue Next Year | $5.08 | N/A |
| P/E Ratio | $24.20 | ★ $3.57 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $68.10 | $6.18 |
| 52 Week High | $94.31 | $17.23 |
Technical Indicators
Market Signals| Indicator | MSM | OGN |
|---|---|---|
| Relative Strength Index (RSI) | 53.40 | 38.66 |
| Support Level | $84.99 | $6.82 |
| Resistance Level | $87.08 | $7.14 |
| Average True Range (ATR) | 2.07 | 0.27 |
| MACD | 0.33 | -0.01 |
| Stochastic Oscillator | 74.14 | 8.20 |
Price Performance
Historical ComparisonAbout MSM MSC Industrial Direct Company Inc.
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations (MRO) supplies. MSC primarily operates within North America where it derives over 95% of its revenue.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.